Bob Reina: Key founder and Chief Executive Officer of Talk Fusion

Bob Reina is the founder of Talk Fusion, a company that deals with video emailing of products. Having achieved an experience for over two decades, Reina champions huge success in the marketing industry. Since Talk Fusion was established back in 2007, it has always been in the forefront when it comes to helping the society. His generous donations towards different non-profit companies brings out his great passion for having the community move ahead. Learn more: http://www.superbcrew.com/talk-fusion-delivers-award-winning-video-communication-products-and-video-marketing-solutions/

 

His goals have always been motivated by his heart of helping non-profit firms across the world. By seeing people achieve their goals and live their dreams through innovation and video marketing, Bob has always loved to hear associates narrate what impact Talk Fusion has made in their lives. Learn more: http://yourmarkontheworld.com/talk-fusion-founder-ceo-bob-reinas-mission-change-lives/

 

According to an interview conducted by inspirery, Bob’s brilliant idea was inspired by a friend who introduced him to network marketing. Due to the monotony and boredom in controlling traffic day in-day out, Bob opted to indulge in marketing and evade the limiting job he had at that time. Although his idea failed at first, he went back to the drawing board. His idea materialized back in North Carolina when a clip he was sending to his family never failed to go through. He then sought help from his IT friend and his idea on Talk Fusion was nurtured.

 

Reina makes money through direct sales. When other people join his company and create a great marketing platform via video emailing, it creates a platform for him to earn. The growth of Talk Fusion to becoming a profitable channel was quite fast. This is because it had an appropriate product which had been developed at the right time.

 

Bob never doubted his start as he only marketed products he believed would penetrate the market. By informing everyone about his business created a channel through which many customers and associates were able to interact with his products. Other than referrals, he also majored in video newsletters, live webinars, and video chats to reach his customers.

 

Self-discipline has always been the key towards him engineering his ideas and juggling through challenges he encountered before Talk Fusion. His greatest joy has always been him achieving his objectives. Through developing new products to the changing world, Bob believes that his business future is very bright. Learn more: https://www.youtube.com/watch?v=73t_xeZFmIQ

 

Amicus Therapeutics Fighting Rare and Orphan Diseases with Relentless Research

Based in Cranbury, New Jersey, Amicus Therapeutics, is a biopharmaceutical company that develops therapeutics for rare and orphan diseases that are called lysosomal storage disorders.

Their platform, CHART, focuses on developing of enzyme replacement therapies with which to treat these lysosomal disorders. They are known in the biopharmaceutical industry as having an abundance of small molecule pharmacological chaperones.

As Amicus Therapeutics does not have the capability of manufacturing their products on their own they must rely on contracting it to other manufacturers, such as JCR Pharmaceutical and GlaxoSmithKline. They worked with them from 2010 to 2013 in investigating the coformulation and recombinant alpha-galactosidase for the advancement of migalastat monotherapy.

Amicus Therapeutics expanded its research facility from New Jersey, opening a second research site in San Diego, California in 2008 (Yahoo Finance). Then in 2010, they were able to collaborate with David Geffen at the School of Medicine,UCLA due to a grant received for $500,000 from the Michael J. Fox Foundation, the same year they received another grant for $210,300 from the Alzheimer’s Drug Discovery Foundation for pre-clinical research with Ichan School of Medicine, Mount Sinai, working with the Alzheimer’s Disease Research Center.

In 2013, a competitor of Amicus, Callidus Biopharma was acquired which gained them intellectual property and proprietary access for an enzyme replacement treatment for Pompe disease, an inherited Lysosomal Storage Disorder caused by the body not producing the enzyme acid alpha-glucosidase or GAA.

https://www.google.com/finance?cid=706165

Their leading product, migalastat, which is used to treat persons with Fabry disease,a disease that can lead to progressive and irreversible organ damage. This disease will affect the nervous system as well as cardiac, renal and a multitude of other tissues. Migalastat is in the late stages of development.

Amicus has built a belief statement to cover their core values plus be a reminder for the reason they do every day what they do. Part of the belief is that they believe in the fight against these diseases, they strive to have the highest quality therapies for anyone with these diseases. They firmly believe in supporting the communities of these diseases and their families.
For job opportunities with Amicus Therapeutics visit Indeed or Twitter

Dr. Richard Shinto and Penelope Kokkinides: Leading InnovaCare Health

InnovaCare Health is a recognized name in the market of health services in North America, specifically in Puerto Rico. This institution has done significant progress over the years and now has the honour of being one of the most renowned providers of managed healthcare services. There are two main avenues of care through which care is provided to the clients, including Medicaid Programs, Medicare Advantage, and Provider Networks. Moreover, InnovaCare Health strives to renovate and bring revolution in the field of healthcare management in order to meet the requirements of the people and provide facilities that are according to the international standards. This medical health care institution always makes sure that patients are prioritized and the relation with them is valued.

No organization can influence the market and be successful among strong competitors without having a clear set of values that would dictate the course of its journey. These values include providing top-notch medical and health care and making patients a top priority. Furthermore, they also make sure that their management team exceeds expectations and keeps up the values of transparency and quality. InnovaCare Health has also enriched the values of corporate integrity, teamwork, problem-solving via communication, experienced leadership, and achieving goals with substantial outcomes.

InnovaCare Health would not have been on the path of success and amongst leading healthcare providers without the efforts of its visionary leadership and team. Dr. Richard Shinto is the President and Chief Executive Officer of InnovaCare, Inc. His 20 years of experience in healthcare makes him a valuable asset to the leadership. Dr. Shinto has also worked as Chief Medical Officer of NAMM California. He has also remained the president and Chief Executive Officer of Aveta Inc. until 2012. Dr. Richard Shinto received his Bachelor’s degree from the University of California at Irvine, and later went to the State University of New York at Stony Brook for his medical degree. Dr. Shinto also has an MBA from the University of Redlands.

Another noteworthy name that is part of InnovaCare, Inc. is Penelope Kokkinides. She is appointed as the Chief Administrative Officer at InnovaCare, Inc. Kokkinides has more than 20 years of experience in medical healthcare, making clinical programs, and managing health care procedures with emphasis on improving infrastructure. Before this, Kokkinides served as the Executive Vice President and Chief Operating Officer at Centerlight HealthCare. Recently, three new experts have joined the leadership board of InnovaCare, Inc., which include Jonathan Meyers, Mike Sortino, and Penelope Kokkinides. All of the personnel mentioned above are expected to contribute to the success of InnovaCare, Inc. with their expertise, high level of experience, and professional skills. Read more about the interview of Penelope in Ideamensch.

One of the Fastest Growing Companies

In order to offer the best service to clients, companies often have to think out-of-the-box. This is definitely one of the main strategies for Status Labs, and apparently it has paid off because they have just been named to the INC 500’s list of the fastest growing companies.

They debuted at number 339 on the list, and they were recognized for their immense, %1.099 growth from 2012 to 2015. They were cited for their great innovations in the public relations and reputation markets. They credited the growth to a number of different factors, including the creation of new digital service offerings that will continue to appeal to more clients worldwide.

We are honored to be named to the Inc. 500 List of fastest-growing companies,” said Darius Fisher. “This achievement is a testament to the increasing demand for not only digital reputation management but also strategic digital PR, SEO and marketing campaigns. We continue to grow, hire and expand, and I feel optimistic about the future of Status Labs.”

Inclusion on this coveted 500 list means that this company will see its bankroll grow immensely and they will be host to a lot of worldwide exposure. Companies such as Pandora, Yelp, Zillow, Dell, Domino’s Pizza, LinkedIn, Timberland have all cracked this exclusive list.

At the helm of Status Labs is CEO Darius Fisher, who is tasked with guiding this company into the 21st Century and beyond. Darius Fisher graduated with honors from Vanderbilt University, and begin his career in business with a position as a Litigation Support Executive with Discovia from 2007 to 2008. He proceeded to become a political consultant with Storefront Political Media from 2008 to 2009, and then he went on to become a Senior Copywriter with Agora Publishing from 2009 to 2011.

He founded Status Labs in January of 2013, and in just three short years he has watched the company grow from a small start-up to an international firm. Through his dynamic leadership, he has spearheaded the company’s international expansion to what it is today: one of the fastest growing reputation firms in the world today.

More information for Darius Fisher:

http://www.businesswire.com/news/home/20150915006953/en/Status-Labs-President-Darius-Fisher-Speak-Impact15